(Q55194670)

25 June 2018

title

Construction of immunoradiometric assay for circulating c-erbB-2 protooncogene product in advanced breast cancer patients. (English)

1 reference

25 June 2018

author name string

M Hosono

1

1 reference

25 June 2018

T Saga

2

1 reference

25 June 2018

H Sakahara

3

1 reference

25 June 2018

H Kobayashi

4

1 reference

25 June 2018

M Shirato

5

1 reference

25 June 2018

K Endo

6

1 reference

25 June 2018

T Yamamoto

7

1 reference

25 June 2018

T Akiyama

8

1 reference

25 June 2018

K Toyoshima

9

1 reference

25 June 2018

J Konishi

10

1 reference

25 June 2018

publication date

1 February 1993

1 reference

25 June 2018

number of pages

6

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

25 June 2018

volume

84

1 reference

25 June 2018

issue

2

1 reference

25 June 2018

page(s)

147-152

1 reference

25 June 2018

Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

Circulating CA 15-3 antigen levels in non-mammary malignancies

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

c-erbB-2 expression in benign and malignant breast disease

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

A murine monoclonal antibody that recognizes an extracellular domain of the human c-erbB-2 protooncogene product

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

The long term prognostic significance of c-erbB-2 in primary breast cancer

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

Scintigraphic detection of overexpressed c-erbB-2 protooncogene products by a class-switched murine anti-c-erbB-2 protein monoclonal antibody

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

Identification of heregulin, a specific activator of p185erbB2

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919131

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

13 August 2018

1 reference

12 December 2020

Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer

1 reference

12 December 2020

c-erbB-2 andras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome

1 reference

12 December 2020

Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors

1 reference

12 December 2020

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

1 reference

12 December 2020

[Development of sandwich radioimmunometric assay for serum c-erbB-2 oncogene product and its significance in diagnosing breast carcinoma]

1 reference

12 December 2020

Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer

1 reference

12 December 2020

10.1111/J.1349-7006.1993.TB02848.X

Identifiers

DOI

1 reference

25 June 2018

PMC publication ID

5919131

1 reference

25 June 2018

PubMed publication ID

8096502

1 reference

25 June 2018